Herts and Essex Fertility - IVF Spot Purchase NCL ICB

The procurement process for the "Herts and Essex Fertility - IVF Spot Purchase NCL ICB" contract has concluded, with a confirmation of the award to HERTS and ESSEX FERTILITY CENTRE LIMITED. This contract falls under the Health Care Services (Provider Selection Regime) Regulations 2023, specifically outside the provisions of the Public Contracts Regulations 2015. NHS North Central London ICB spearheaded this process, which pertains to the provision of in vitro fertilisation services.

The procurement was carried out using a limited method, bypassing the call for competition, due to its regulation under the Provider Selection Regime. This contract was officially signed on 2nd June 2025, for delivery in the UKH2 region. This procurement presents valuable opportunities for businesses specialising in health services, particularly those dealing with fertility treatments.

The nature of the contract as a spot purchase allows service providers to potentially establish long-term collaborations with NHS bodies. Small to medium enterprises in the health sector, similar to HERTS and ESSEX FERTILITY CENTRE LIMITED, which successfully secured the contract, are well-suited to participate in such tenders given the right credentials and service quality. Such opportunities enable businesses to expand their portfolios by providing essential health services within the regulatory framework of the Provider Selection Regime.